Duke University Hospital Cancer Center
GPTKB entity
Statements (52)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
6
|
gptkbp:bfsParent |
gptkb:Duke_Health_system
|
gptkbp:accreditation |
gptkb:healthcare_organization
gptkb:American_College_of_Surgeons |
gptkbp:affiliated_with |
gptkb:Duke_University
|
gptkbp:clinical_trial |
observational studies
Phase III trials Phase I trials Phase II trials registry studies |
gptkbp:collaborates_with |
other research institutions
|
gptkbp:community_involvement |
support groups
educational workshops screening programs survivorship programs cancer awareness |
gptkbp:has_part |
gptkb:Duke_Clinical_Research_Institute
gptkb:Duke_Cancer_Institute Duke Center for Cancer Genomics Duke Center for Cancer Immunotherapy |
gptkbp:has_programs |
hematology
pediatric oncology surgical oncology medical oncology radiation oncology adult oncology |
https://www.w3.org/2000/01/rdf-schema#label |
Duke University Hospital Cancer Center
|
gptkbp:located_in |
gptkb:Durham,_North_Carolina
|
gptkbp:offers |
gptkb:hospital
radiation therapy chemotherapy genetic counseling nutrition services psychosocial support oncology services clinical trials for new therapies |
gptkbp:part_of |
gptkb:Duke_University_Health_System
|
gptkbp:population |
diverse backgrounds
various age groups different cancer types |
gptkbp:provides |
palliative care
patient support services telehealth services |
gptkbp:receives_funding_from |
gptkb:Research_Institute
pharmaceutical companies private foundations |
gptkbp:research_focus |
gptkb:healthcare_organization
clinical trials cancer prevention cancer genetics |
gptkbp:specialization |
gptkb:healthcare_organization
|